genprowebdirectory
  • GEN Edge
    • Featured News
    • Multimedia
    • Subscribe
    • Login
    • Contributors
  • News
  • Insights
    • Trends for 2020
    • Trends for 2021
    • Trends for 2023
  • Topics
    • Artificial Intelligence
    • Bioprocessing
    • Cancer
    • Drug Discovery
    • Genome Editing
    • Infectious Diseases
    • OMICs
    • Translational Medicine
  • A-Lists
  • Magazine
    • Current Issue
    • Past Issues
    • Supplements
    • Subscribe
  • Multimedia
    • Summits
    • Webinars
    • Learning Labs
    • GEN Live
    • Podcasts
  • Resources
    • eBooks/Perspectives
    • Tutorials
    • Biotech Briefs
    • Peer-Reviewed Journals
      • GEN Biotechnology
      • Re:Gen Open
    • New Products
    • Best of the Web
    • Best Apps
    • Conference Calendar
  • Subscribe
    • Get GEN Magazine
    • Get GEN eNewsletters
    • Get GEN Edge
Search
Sign in
Welcome! Log into your account
Forgot your password? Get help
Privacy Policy
Password recovery
Recover your password
A password will be e-mailed to you.
Genetic Engineering & Biotechnology News GEN – Genetic Engineering and Biotechnology News
Genetic Engineering & Biotechnology News Genetic Engineering & Biotechnology News
  • GEN Edge
    • Featured News
    • Multimedia
    • Subscribe
    • Login
    • Contributors
  • News
    • Lung Cancer
      Cancer

      Changing Carcinogenic Cells in the Lungs with Novel Technology

      Human microbiome
      Gastrointestinal Disorders

      GI GVHD Link to Microbiome Dysbiosis Addressed by Reducing Intestinal Oxygen

      Cancer

      Molecular Anchor Creates More Effective CAR T Immunotherapies

      White House
      Cancer

      White House Continues Dedication to “End Cancer as We Know It”

      Cancer Cells
      Cancer

      Molecular Pathways Used by Metastatic Cancer Cells Uncovered

  • Insights
    • AllTrends for 2020Trends for 2021Trends for 2023
      ames Watson and Francis Crick
      OMICs

      Reflections on the Double Helix’s Platinum Anniversary

      Evozyne’s office in Chicago, IL
      Artificial Intelligence

      AI and Computational Design Advance Protein Engineering

      Woman Checking label in lab
      Bioprocessing

      In Pursuit of Rare, Subtle, and Fleeting Post-Translational Modifications

      Clear Labs male worker
      Infectious Diseases

      Tripledemic Rouses Vaccine Developers and Variant Trackers

  • Topics
    • Artificial Intelligence
    • Bioprocessing
    • Cancer
    • Drug Discovery
    • Genome Editing
    • Infectious Diseases
    • OMICs
    • Translational Medicine
  • A-Lists
    • Hand Shake Meetings
      Drug Discovery

      Seven Biopharma Trends to Watch in 2023

      NIH Building
      A-Lists

      Top 50 NIH-Funded Institutions of 2022

      Bristol Myers Squibb building
      A-Lists

      Top 10 U.S. Biopharma Clusters

      Biomarker
      A-Lists

      Top 10 Spatial Biology Companies

      stocks go up
      A-Lists

      Top 25 Biotech Companies of 2022

  • Magazine
    • Current Issue
    • Past Issues
    • Supplements
    • Subscribe
  • Multimedia
    • Summits
    • Webinars
    • Learning Labs
    • GEN Live
    • Podcasts
  • Resources
    • eBooks/Perspectives
    • Tutorials
    • Biotech Briefs
    • Peer-Reviewed Journals
      • GEN Biotechnology
      • Re:Gen Open
    • New Products
    • Best of the Web
    • Best Apps
    • Conference Calendar
  • Subscribe
    • Get GEN Magazine
    • Get GEN eNewsletters
    • Get GEN Edge
Home Resources Podcasts John Sterling talks with Bruce H. Littman, M.D., Vice President and Head,...
  • Resources
  • Podcasts

John Sterling talks with Bruce H. Littman, M.D., Vice President and Head, Global Translational Medicine, Pfizer Global Research and Development about translational medicine.

April 20, 2006
0

Share
Facebook
Twitter
Linkedin
ReddIt
Email
    /wp-content/uploads/2018/09/gc_22.mp3
    Share
    Facebook
    Twitter
    Linkedin
    ReddIt
    Email
      Previous articleMicrosoft Establishes the BioIT Alliance
      Next articleDr. Leroy Hood M.D. Co-founder of the Institute for Systems Biology in Seattle, Washington talks with GEN Editor-in-Chief John Sterling about Systems Biology.
      GEN Staff Writer

      RELATED CONTENTMORE FROM AUTHOR

      Best Apps

      Vectornator

      Best Apps

      Calculator #

      Best Apps

      Neurosurgical Atlas

      LEAVE A REPLY Cancel reply

      Log in to leave a comment

      Recently Featured

      Changing Carcinogenic Cells in the Lungs with Novel Technology

      Changing Carcinogenic Cells in the Lungs with Novel Technology

      GI GVHD Link to Microbiome Dysbiosis Addressed by Reducing Intestinal Oxygen

      GI GVHD Link to Microbiome Dysbiosis Addressed by Reducing Intestinal Oxygen

      White House Continues Dedication to “End Cancer as We Know It”

      White House Continues Dedication to “End Cancer as We Know It”

      Molecular Pathways Used by Metastatic Cancer Cells Uncovered

      Molecular Pathways Used by Metastatic Cancer Cells Uncovered

      Read the Digital Edition

      GEN February 2023 cover

      Explore

      • About GEN
      • Contact GEN
      • GEN Staff
      • Editorial Guidelines
      • Reprints and Permissions
      • Scientific Advisory Board

      Advertise

      • Media Kit and Planning Calendar
      • Magazine Advertising
      • Website Banner Advertising
      • eNewsletter Advertising
      • Webinar Sponsorship
      • eBook Advertising
      • List Rental
      • Advertising Terms and Conditions

      Resources

      • Get the GEN Magazine
      • Get the GEN Email Newsletter
      • Inside Precision Medicine
      • New Products
      • Videos
      • Webinars
      • Podcasts
      • Privacy Policy
      • Home
      • Terms of Service
      • Privacy Policy
      • Cookie Policy
      • Mary Ann Liebert, Inc.
      Copyright © 2023 Genetic Engineering & Biotechnology News. All Rights Reserved.
      sponsored
      Scroll Up
      MORE STORIES

      MAGNETICALLY DRIVEN NANOPARTICLE GENE DELIVERY

      Stapled Peptides Making Progress